Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

Delayed Data
As of Nov 27
 +0.07 / +0.08%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 21 analysts offering 12-month price forecasts for Valeant Pharmaceuticals have a median target of 170.00, with a high estimate of 300.00 and a low estimate of 98.00. The median estimate represents a +95.20% increase from the last price of 87.09.

Analyst Recommendations

The current consensus among 23 polled investment analysts is to Buy stock in Valeant Pharmaceuticals. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 25

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 30.16%
Growthannually 34.58%


Growthquarterly 11.60%
Growthannually 30.89%
Key to the earnings and sales forecast charts.